September 21, 2021 - … Uniquely positioned to lead in Alzheimer’s disease with ADUHELM ® (aducanumab-avwa) and industry-leading pipeline … Alzheimer’s disease pipeline with the recent FDA-approved ADUHELM serving as the foundation of a multi-target, … Alzheimer’s disease franchise. In addition to ADUHELM, the company will present progress on lecanemab …